Clinical Trials Directory

Trials / Unknown

UnknownNCT00484133

Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Onze Lieve Vrouwe Gasthuis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to asses the recovery of organ failure between two resuscitation protocols in severe sepsis: standard, pressure guided therapy versus a microcirculation guided therapy

Detailed description

Despite continued improvements in medical therapy, mortality from septic shock has remained between 30% and 70% for the past three decades with only a slight decrease in mortality rate. Standard treatment of septic shock is fluid resuscitation, followed by agents with vasopressor activity to correct hypotension in septic shock. The question rises whether vasopressors should be the first line of action in septic shock Opening and recruiting the microcirculation are expected to improve regional organ function and tissue distress in severe sepsis. Beside fluid resuscitation, vasodilatation, in this respect, enhances microcirculatory flow while vasoconstriction causes a reduction in microcirculatory flow. On the other hand, a minimal perfusion pressure should be present. Our aim is to asses the effects of two resuscitation protocols in severe sepsis: the "standard treatment" using predefined pressure goals versus a microcirculation guided therapy.

Conditions

Interventions

TypeNameDescription
DRUGDopamine
DRUGdobutamine
DRUGenoximone
DRUGnitroglycerine
DRUGnoradrenaline

Timeline

Start date
2007-06-01
Primary completion
2008-12-01
First posted
2007-06-08
Last updated
2008-01-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00484133. Inclusion in this directory is not an endorsement.